Securities code: 002252 securities abbreviation: Shanghai Raas Blood Products Co.Ltd(002252) Announcement No.: 2021-070 Shanghai Raas Blood Products Co.Ltd(002252)
About the resumption of production of intravenous human immunoglobulin in Zhengzhou Laishi, a wholly-owned subsidiary
Announcement of
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Shanghai Raas Blood Products Co.Ltd(002252) (the “company”) disclosed on September 23, 2021 the
<药品补充申请批准通知书>
Zhengzhou Laishi blood products Co., Ltd. (“Zhengzhou Laishi”), a wholly-owned subsidiary of the company, obtained the notice of approval for supplementary drug application for intravenous injection of human immunoglobulin (pH4) issued by the State Drug Administration In the follow-up, the production of Zhengzhou Raffles intravenous immunoglobulin production line can be resumed only after the production site of the above project is verified by Henan food and drug administration.
From December 13 to 15, 2021, the audit and inspection center of Henan food and Drug Administration conducted compliance inspection on the resumption of production of intravenous human immunoglobulin in Zhengzhou Laishi. Recently, Zhengzhou Laishi has completed the rectification of the general defects proposed by the on-site inspection, and the production line of Zhengzhou Laishi intravenous human immunoglobulin can officially resume production. So far, Zhengzhou Laishi human serum albumin and intravenous human immunoglobulin can be put into production normally.
In view of the small proportion of the plasma collection volume of the two single plasma collection stations under Zhengzhou Laishi in the total plasma collection volume of the company, the resumption of production by intravenous injection of human immunoglobulin will not have an important impact on the operating performance of the company in that year.
It is hereby announced.
Shanghai Raas Blood Products Co.Ltd(002252)
Board of directors
December 28, 2001
